Evidence map›Paper›PMID 39175754›Full record

ReviewFrontiers in genetics2024

The role of primary cilia in congenital heart defect-associated neurological impairments.

Nemanja Sarić, Nobuyuki Ishibashi

Abstract readReview
In one paragraph

Review in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Novel compound heterozygous mutation inMolecular medicine reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nemanja SarićCenter for Neuroscience Research, Children's National Medical Center, Washington, DC, United States.
Nobuyuki IshibashiCenter for Neuroscience Research, Children's National Medical Center, Washington, DC, United States.

Funding

Cell Therapy for Neuroprotection in Congenital Heart DiseaseR01HL139712 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI Nobuyuki Ishibashi · 2018 to 2026
$5.7M
White Matter Protection in the Fetus with Congenital Heart DiseaseR01HL146670 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI ISHIBASHI, NOBUYUKI · 2020 to 2023
$3.3M
The developmental origins and fate of neurons in the gyrencephalic neocortexR21NS127051 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI HAYDAR, TARIK F, ISHIBASHI, NOBUYUKI · 2022 to 2023
$491k
NHLBI NIH HHS R01 HL139712NHLBI NIH HHS R01 HL146670
6 · The paper itself

Abstract

Congenital heart disease (CHD) has, despite significant improvements in patient survival, increasingly become associated with neurological deficits during infancy that persist into adulthood. These impairments afflict a wide range of behavioral domains including executive function, motor learning and coordination, social interaction, and language acquisition, reflecting alterations in multiple brain areas. In the past few decades, it has become clear that CHD is highly genetically heterogeneous, with large chromosomal aneuploidies and copy number variants (CNVs) as well as single nucleotide polymorphisms (SNPs) being implicated in CHD pathogenesis. Intriguingly, many of the identified loss-of-function genetic variants occur in genes important for primary cilia integrity and function, hinting at a key role for primary cilia in CHD. Here we review the current evidence for CHD primary cilia associated genetic variants, their independent functions during cardiac and brain development and their influence on behavior. We also highlight the role of environmental exposures in CHD, including stressors such as surgical factors and anesthesia, and how they might interact with ciliary genetic predispositions to determine the final neurodevelopmental outcome. The multifactorial nature of CHD and neurological impairments linked with it will, on one hand, likely necessitate therapeutic targeting of molecular pathways and neurobehavioral deficits shared by disparate forms of CHD. On the other hand, strategies for better CHD patient stratification based on genomic data, gestational and surgical history, and CHD complexity would allow for more precise therapeutic targeting of comorbid neurological deficits.

Indexed as

brainciliacongenital heart diseasegenetic variantsneurodevelopment

Identifiers

PMID39175754
PMCPMC11338889

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.